Business Description
Chenguang Biotech Group Co Ltd
NAICS : 325998
ISIN : CNE100000WC5
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.36 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 1.22 | |||||
Debt-to-EBITDA | 6.63 | |||||
Interest Coverage | 6.22 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 2.29 | |||||
Beneish M-Score | -1.66 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 18.8 | |||||
3-Year EBITDA Growth Rate | 14.5 | |||||
3-Year EPS without NRI Growth Rate | 15.7 | |||||
3-Year Book Growth Rate | 18 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.85 | |||||
9-Day RSI | 31.86 | |||||
14-Day RSI | 32.59 | |||||
6-1 Month Momentum % | -16.69 | |||||
12-1 Month Momentum % | -39.37 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.61 | |||||
Quick Ratio | 0.8 | |||||
Cash Ratio | 0.38 | |||||
Days Inventory | 129.95 | |||||
Days Sales Outstanding | 20.06 | |||||
Days Payable | 2.87 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.76 | |||||
Dividend Payout Ratio | 0.18 | |||||
3-Year Dividend Growth Rate | 47.4 | |||||
Forward Dividend Yield % | 1.76 | |||||
5-Year Yield-on-Cost % | 1.87 | |||||
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | -16.87 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 11.61 | |||||
Operating Margin % | 7.56 | |||||
Net Margin % | 6.98 | |||||
FCF Margin % | -6.65 | |||||
ROE % | 14.25 | |||||
ROA % | 6.35 | |||||
ROIC % | 8.18 | |||||
ROC (Joel Greenblatt) % | 13.5 | |||||
ROCE % | 15.1 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 10.25 | |||||
PE Ratio without NRI | 10.4 | |||||
Shiller PE Ratio | 21.05 | |||||
Price-to-Owner-Earnings | 18.35 | |||||
PEG Ratio | 0.46 | |||||
PS Ratio | 0.73 | |||||
PB Ratio | 1.42 | |||||
Price-to-Tangible-Book | 1.56 | |||||
EV-to-EBIT | 11.87 | |||||
EV-to-EBITDA | 11.87 | |||||
EV-to-Revenue | 1.1 | |||||
EV-to-FCF | -9.93 | |||||
Price-to-DCF (Earnings Based) | 0.33 | |||||
Price-to-Median-PS-Value | 0.42 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.42 | |||||
Price-to-Graham-Number | 0.85 | |||||
Price-to-Net-Current-Asset-Value | 3.8 | |||||
Earnings Yield (Greenblatt) % | 8.42 | |||||
FCF Yield % | -15.76 | |||||
Forward Rate of Return (Yacktman) % | 16.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Chenguang Biotech Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 6,785.98 | ||
EPS (TTM) (Â¥) | 0.722 | ||
Beta | 0.75 | ||
Volatility % | 32.61 | ||
14-Day RSI | 32.59 | ||
14-Day ATR (Â¥) | 0.421398 | ||
20-Day SMA (Â¥) | 10.518 | ||
12-1 Month Momentum % | -39.37 | ||
52-Week Range (Â¥) | 8.9 - 18.93 | ||
Shares Outstanding (Mil) | 532.77 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Chenguang Biotech Group Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Chenguang Biotech Group Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Chenguang Biotech Group Co Ltd Frequently Asked Questions
What is Chenguang Biotech Group Co Ltd(SZSE:300138)'s stock price today?
When is next earnings date of Chenguang Biotech Group Co Ltd(SZSE:300138)?
Does Chenguang Biotech Group Co Ltd(SZSE:300138) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |